Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-30
DOI
10.3389/fimmu.2022.825367
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor
- (2021) Shinsuke Kataoka et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Type I Interferonopathies in Children: An Overview
- (2021) Debora M. d'Angelo et al. Frontiers in Pediatrics
- JAK inhibition in the type I interferonopathies
- (2021) Yanick J. Crow et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Translating JAKs to Jakinibs
- (2020) Massimo Gadina et al. JOURNAL OF IMMUNOLOGY
- Janus Kinase Inhibition in the Aicardi–Goutières Syndrome
- (2020) Adeline Vanderver et al. NEW ENGLAND JOURNAL OF MEDICINE
- Successful treatment of spondyloenchondrodysplasia with baricitinib
- (2020) Masaki Shimizu et al. RHEUMATOLOGY
- Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients
- (2020) Marie-Louise Frémond et al. Journal of Allergy and Clinical Immunology-In Practice
- Self-Awareness: Nucleic Acid–Driven Inflammation and the Type I Interferonopathies
- (2019) Carolina Uggenti et al. Annual Review of Immunology
- Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome
- (2019) Stefano Volpi et al. JOURNAL OF CLINICAL IMMUNOLOGY
- STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib
- (2019) Xiaolei Tang et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
- (2018) Gina A. Montealegre Sanchez et al. JOURNAL OF CLINICAL INVESTIGATION
- An open-label trial of JAK 1/2 blockade in progressive IFIH1 -associated neuroinflammation
- (2018) Kavitha Kothur et al. NEUROLOGY
- A Mutation Outside the Dimerization Domain Causing Atypical STING-Associated Vasculopathy With Onset in Infancy
- (2018) Rohit G. Saldanha et al. Frontiers in Immunology
- Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency
- (2018) Coralie Briand et al. ANNALS OF THE RHEUMATIC DISEASES
- Reverse-Transcriptase Inhibitors in the Aicardi–Goutières Syndrome
- (2018) Gillian I. Rice et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Type I interferonopathy in a young adult
- (2017) Menelaos N. Manoussakis et al. RHEUMATOLOGY
- Familial chilblain lupus due to a gain-of-function mutation in STING
- (2016) Nadja König et al. ANNALS OF THE RHEUMATIC DISEASES
- Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster
- (2016) Kunihiro Yamaoka DRUG SAFETY
- Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children
- (2016) Marie-Louise Frémond et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
- (2016) Gillian I. Rice et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Type I interferonopathies: Mendelian type I interferon up-regulation
- (2015) Yanick J Crow CURRENT OPINION IN IMMUNOLOGY
- Type I interferonopathies: a novel set of inborn errors of immunity
- (2011) Yanick J. Crow Annals of the New York Academy of Sciences
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now